Dr. Brian Merritt, M.D

NPI: 1093045247
Total Payments
$6,668
2023 Payments
$19.01
Companies
2
Transactions
7
Medicare Patients
114
Medicare Billing
$3,534

Payment Breakdown by Category

Other$5,640 (84.6%)
Travel$916.76 (13.7%)
Food & Beverage$110.81 (1.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $3,320 1 49.8%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,320 1 34.8%
Travel and Lodging $916.76 3 13.7%
Food and Beverage $110.81 2 1.7%

Top Paying Companies

Company Total Records Latest Year
NOVARTIS PHARMACEUTICALS CORPORATION $6,649 6 $0 (2019)
AngioDynamics, Inc. $19.01 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2023 $19.01 1 AngioDynamics, Inc. ($19.01)
2019 $2,966 4 NOVARTIS PHARMACEUTICALS CORPORATION ($2,966)
2018 $3,683 2 Novartis Pharmaceuticals Corporation ($3,683)

All Payment Transactions

7 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
03/03/2023 AngioDynamics, Inc. BIOSENTRY TRACT SEALANT SYSTEM (Device) Food and Beverage In-kind items and services $19.01 General
Category: OS
02/14/2019 NOVARTIS PHARMACEUTICALS CORPORATION PIQRAY (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,320.00 General
Category: ONCOLOGY
02/14/2019 NOVARTIS PHARMACEUTICALS CORPORATION PIQRAY (Drug) Travel and Lodging In-kind items and services $293.92 General
Category: ONCOLOGY
02/14/2019 NOVARTIS PHARMACEUTICALS CORPORATION PIQRAY (Drug) Travel and Lodging Cash or cash equivalent $259.84 General
Category: ONCOLOGY
02/14/2019 NOVARTIS PHARMACEUTICALS CORPORATION PIQRAY (Drug) Food and Beverage In-kind items and services $91.80 General
Category: ONCOLOGY
01/17/2018 Novartis Pharmaceuticals Corporation RYDAPT (Drug) Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program Cash or cash equivalent $3,320.00 General
Category: HEMATOLOGY
01/16/2018 Novartis Pharmaceuticals Corporation RYDAPT (Drug) Travel and Lodging In-kind items and services $363.00 General
Category: HEMATOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 42 52 $11,491 $2,315
2022 1 32 36 $1,836 $512.14
2021 2 40 40 $2,320 $706.70
Total Patients
114
Total Services
128
Medicare Billing
$3,534
Procedure Codes
6

All Medicare Procedures & Services

6 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
88305 Pathology examination of tissue using a microscope, intermediate complexity Office 2023 12 22 $7,700 $1,293 16.8%
88189 Flow cytometry technique for dna or cell analysis, 16 or more markers Office 2023 11 11 $2,860 $754.38 26.4%
84165 Protein measurement, serum Facility 2023 19 19 $931.00 $267.15 28.7%
84165 Protein measurement, serum Facility 2022 32 36 $1,836 $512.14 27.9%
85060 Blood smear interpretation by physician with written report Facility 2021 24 24 $1,536 $474.95 30.9%
84165 Protein measurement, serum Facility 2021 16 16 $784.00 $231.75 29.6%

About Dr. Brian Merritt, M.D

Dr. Brian Merritt, M.D is a Anatomic Pathology & Clinical Pathology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/11/2010. The National Provider Identifier (NPI) number assigned to this provider is 1093045247.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Merritt, M.D has received a total of $6,668 in payments from pharmaceutical and medical device companies, with $19.01 received in 2023. These payments were reported across 7 transactions from 2 companies. The most common payment nature is "Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program" ($3,320).

As a Medicare-enrolled provider, Merritt has provided services to 114 Medicare beneficiaries, totaling 128 services with total Medicare billing of $3,534. Data is available for 3 years (2021–2023), covering 6 distinct procedure/service records.

Practice Information

Products in Payments

  • RYDAPT (Drug) $3,683
  • PIQRAY (Drug) $2,966
  • BIOSENTRY TRACT SEALANT SYSTEM (Device) $19.01

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Anatomic Pathology & Clinical Pathology Doctors in Houston